SciClone Pharmaceuticals Inc (NASDAQ:SCLN) - Overview

Stock Report

SciClone Pharmaceuticals Inc SCLN

Last Price
$10.50

Day Change
0.20|1.94%

As of 06/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close10.30
Day Range10.20 - 10.50
Mkt Cap536.10Mil
52-Wk Range7.37 - 15.03
Yield %-
ISINUS80862K1043
Volume494,964
P/E15.00
P/S3.45
P/CF16.59

Share Price

Financials
201320142015
More ...
Income Statement
Revenue127.06134.79157.26
Operating Income10.4325.9829.91
Net Income10.9625.2129.46
Basic EPS0.200.490.59
Avg. Diluted Shares Outstanding555352
Balance Sheet
Current Assets143.41140.20168.52
Non Current Assets36.8241.6348.10
Total Assets180.23181.83216.62
Current Liabilities33.5926.4436.82
Total Liabilities33.6326.5636.91
Total Equity146.60155.27179.71
Cash Flow
Operating Cash Flow9.5027.6132.51
Capital Expenditure-0.32-1.45-1.84
Free Cash Flow9.1826.1630.67

In millions, except "Basic EPS". Currency is USD.

Company Profile

SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

590
Key Stats
More ...
Price/Earning TTM13.92
Price/Book2.52
Price/Sales TTM3.33
Rev Growth (3 year avg)0.21
EPS Growth (3 year avg)-
Operating Margin % TTM19.02
Net Margin % TTM18.74
ROE TTM17.59
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.